Oral Delivery of Meglumine Antimoniate-β-Cyclodextrin Complex for Treatment of Leishmaniasis
Open Access
- 1 January 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (1), 100-103
- https://doi.org/10.1128/aac.48.1.100-103.2004
Abstract
The need for daily parenteral administration represents one of the most serious limitations in the clinical use of pentavalent antimonials against leishmaniasis. In this work, we investigated the ability of β-cyclodextrin to enhance the oral absorption of antimony and to promote the oral efficacy of meglumine antimoniate against experimental cutaneous leishmaniasis. The occurrence of interactions between β-cyclodextrin and meglumine antimoniate was demonstrated through the changes induced in the spin lattice relaxation times of protons in both compounds. When free and complexed meglumine antimoniate were given orally to Swiss mice, plasma antimony levels were found to be about three times higher for the meglumine antimoniate-β-cyclodextrin complex than for the free drug. Antileishmanial efficacy was evaluated in BALB/c mice experimentally infected with Leishmania amazonensis . Animals treated daily with the complex (32 mg of Sb/kg of body weight) by the oral route developed significantly smaller lesions than those treated with meglumine antimoniate (120 mg of Sb/kg) and control animals (treated with saline). The effectiveness of the complex given orally was equivalent to that of meglumine antimoniate given intraperitoneally at a twofold-higher antimony dose. The antileishmanial efficacy of the complex was confirmed by the significantly lower parasite load in the lesions of treated animals than in saline-treated controls. This work reports for the first time the effectiveness of an oral formulation for pentavalent antimonials.Keywords
This publication has 13 references indexed in Scilit:
- Formulation of amphotericin B as nanosuspension for oral administrationInternational Journal of Pharmaceutics, 2003
- Pentavalent organoantimonial derivatives: two simple and efficient synthetic methods for meglumine antimonateApplied Organometallic Chemistry, 2003
- Oral Miltefosine for Indian Visceral LeishmaniasisNew England Journal of Medicine, 2002
- Cyclodextrin-based controlled drug release systemAdvanced Drug Delivery Reviews, 1999
- Iridium and Rhodium as Permanent Chemical Modifiers for the Determination of Ag, As, Bi, Cd, and Sb by Electrothermal Atomic Absorption SpectrometryMicrochemical Journal, 1998
- NMR Studies of Cyclodextrins and Cyclodextrin ComplexesChemical Reviews, 1998
- Cyclodextrin Drug Carrier SystemsChemical Reviews, 1998
- Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety EvaluationJournal of Pharmaceutical Sciences, 1997
- Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future StrategiesClinical Infectious Diseases, 1988
- β‐Cyclodextrin Dodecahydrate: Crowding of Water Molecules within a Hydrophobic CavityAngewandte Chemie-International Edition, 1978